Loading clinical trials...
Loading clinical trials...
A Phase 1, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Evidence of Antitumor Activity of ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies
Conditions
Interventions
ZZ06
Locations
5
United States
Cedars Sinai Medical Center
Los Angeles, California, United States
Kansas University Cancer Center
Fairway, Kansas, United States
Montefiore Medical Center
The Bronx, New York, United States
Jilin Cancer Hospital
Changchun, Jilin, China
The first Bethune hospital of Jilin University
Changchun, Jilin, China
Start Date
September 1, 2020
Primary Completion Date
December 1, 2025
Completion Date
July 6, 2026
Last Updated
June 10, 2025
Lead Sponsor
Changchun Intellicrown Pharmaceutical Co. LTD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions